These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 28948086)
1. Detection and application of neurochemical profile by multiple regional Guan J; Rong Y; Wen Y; Wu H; Qin H; Zhang Q; Chen W Brain Behav; 2017 Sep; 7(9):e00792. PubMed ID: 28948086 [TBL] [Abstract][Full Text] [Related]
2. Region-specific Cerebral Metabolic Alterations in Parkinson's Disease Patients With/without Mild Cognitive Impairment. Huang M; Yu H; Lyu X; Pu W; Yin J; Gao B Neuroscience; 2024 Jul; 551():254-261. PubMed ID: 38848776 [TBL] [Abstract][Full Text] [Related]
3. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting. Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939 [TBL] [Abstract][Full Text] [Related]
4. Similarities of biochemical abnormalities between major depressive disorder and bipolar depression: a proton magnetic resonance spectroscopy study. Zhong S; Wang Y; Zhao G; Xiang Q; Ling X; Liu S; Huang L; Jia Y J Affect Disord; 2014 Oct; 168():380-6. PubMed ID: 25106035 [TBL] [Abstract][Full Text] [Related]
5. Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment. Nie K; Zhang Y; Huang B; Wang L; Zhao J; Huang Z; Gan R; Wang L Parkinsonism Relat Disord; 2013 Mar; 19(3):329-34. PubMed ID: 23238068 [TBL] [Abstract][Full Text] [Related]
6. Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson's disease. Zhou B; Yuan F; He Z; Tan C Brain Imaging Behav; 2014 Mar; 8(1):97-101. PubMed ID: 23955491 [TBL] [Abstract][Full Text] [Related]
7. Proton MR spectroscopic changes in Parkinson's diseases after thalamotomy. Baik HM; Choe BY; Son BC; Jeun SS; Kim MC; Lee KS; Kim BS; Lee JM; Lee HK; Suh TS Eur J Radiol; 2003 Sep; 47(3):179-87. PubMed ID: 12927660 [TBL] [Abstract][Full Text] [Related]
8. Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study. Ciurleo R; Bonanno L; Di Lorenzo G; Bramanti P; Marino S Neurosci Lett; 2015 Jul; 599():55-60. PubMed ID: 26007705 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Braak staging of brain pathology with Cao H; Shi J; Cao B; Kang B; Zhang M; Qu Q Neurosci Lett; 2017 Nov; 660():57-62. PubMed ID: 28844732 [TBL] [Abstract][Full Text] [Related]
11. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment. Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281 [TBL] [Abstract][Full Text] [Related]
12. Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy. Choe BY; Park JW; Lee KS; Son BC; Kim MC; Kim BS; Suh TS; Lee HK; Shinn KS Invest Radiol; 1998 Aug; 33(8):450-5. PubMed ID: 9704284 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease. Weiduschat N; Mao X; Beal MF; Nirenberg MJ; Shungu DC; Henchcliffe C J Neuroimaging; 2015; 25(1):105-10. PubMed ID: 24325203 [TBL] [Abstract][Full Text] [Related]
14. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control? Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777 [TBL] [Abstract][Full Text] [Related]
15. Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study. Ellis CM; Lemmens G; Williams SC; Simmons A; Dawson J; Leigh PN; Chaudhuri KR Neurology; 1997 Aug; 49(2):438-44. PubMed ID: 9270574 [TBL] [Abstract][Full Text] [Related]
16. MRS study on lentiform nucleus in idiopathic Parkinson's disease with unilateral symptoms. Zheng XN; Zhu XC; Ruan LX; Zhang LJ; Yuan M; Shang DS; Liu Y J Zhejiang Univ Sci; 2004 Feb; 5(2):246-50. PubMed ID: 14674041 [TBL] [Abstract][Full Text] [Related]
17. Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study. Wang S; Yuan J; Guo X; Peng P; Gu H; Niu S; Fregni F; Chen AC; Hu W Neurol Res; 2012 Dec; 34(10):989-97. PubMed ID: 23146302 [TBL] [Abstract][Full Text] [Related]
18. Metabolic abnormality of pontine tegmentum in patients with REM sleep behavior disorder analyzed using magnetic resonance spectroscopy. Zhang L; Xu Y; Zhuang J; Peng H; Wu H; Zhao Z; He B; Zhao Z Clin Neurol Neurosurg; 2016 Sep; 148():137-41. PubMed ID: 27448046 [TBL] [Abstract][Full Text] [Related]
19. Brain morphological alterations and cellular metabolic changes in patients with generalized anxiety disorder: A combined DARTEL-based VBM and (1)H-MRS study. Moon CM; Jeong GW Magn Reson Imaging; 2016 May; 34(4):429-36. PubMed ID: 26708039 [TBL] [Abstract][Full Text] [Related]
20. Metabolic alterations in Parkinson's disease after thalamotomy, as revealed by 1H MR spectroscopy. Baik HM; Choe BY; Lee HK; Suh TS; Son BC; Lee JM Korean J Radiol; 2002; 3(3):180-8. PubMed ID: 12271163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]